Evaluation of the bioactive properties of avenanthramide analogs produced in recombinant yeast.

Evaluation of the bioactive properties of avenanthramide analogs produced in recombinant yeast.

Item
http://www.wikidata.org/entity/Q38914490
Exploiting members of the BAHD acyltransferase family to synthesize multiple hydroxycinnamate and benzoate conjugates in yeast.Defective autophagy is a key feature of cerebral cavernous malformations.Cytochrome P450 and matrix metalloproteinase genetic modifiers of disease severity in Cerebral Cavernous Malformation type 1.Introduction to cerebral cavernous malformation: a brief review.Up-regulation of NADPH oxidase-mediated redox signaling contributes to the loss of barrier function in KRIT1 deficient endothelium.Beyond multiple mechanisms and a unique drug: Defective autophagy as pivotal player in cerebral cavernous malformation pathogenesis and implications for targeted therapies.Oxidative stress and inflammation in cerebral cavernous malformation disease pathogenesis: Two sides of the same coin.Avenanthramide-C reduces the viability of MDA-MB-231 breast cancer cells through an apoptotic mechanism.Platinum nanozymes recover cellular ROS homeostasis in an oxidative stress-mediated disease model.KRIT1 loss-of-function induces a chronic Nrf2-mediated adaptive homeostasis that sensitizes cells to oxidative stress: Implication for Cerebral Cavernous Malformation disease.Yeast-Derived Recombinant Avenanthramides Inhibit Proliferation, Migration and Epithelial Mesenchymal Transition of Colon Cancer CellsBiological Activities, Health Benefits, and Therapeutic Properties of Avenanthramides: From Skin Protection to Prevention and Treatment of Cerebrovascular Diseases
P2860

Evaluation of the bioactive properties of avenanthramide analogs produced in recombinant yeast.

Item
http://www.wikidata.org/entity/Q38914490
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Evaluation of the bioactive pr ...... produced in recombinant yeast.
@en
type
label
Evaluation of the bioactive pr ...... produced in recombinant yeast.
@en
prefLabel
Evaluation of the bioactive pr ...... produced in recombinant yeast.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P356
P1433
P1476
Evaluation of the bioactive pr ...... produced in recombinant yeast
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698